瑞阳（苏州）生物科技

Reyoung (Suzhou) Biotechnology is a research and development-focused subsidiary of Reyoung Pharmaceutical, located in the Suzhou Industrial Park. The company specializes in the discovery and development of innovative biologics and small molecule drugs, with a primary focus on oncology and metabolic diseases. Leveraging the manufacturing and commercialization strengths of its parent company, Reyoung (Suzhou) aims to advance a pipeline of high-potential candidates through clinical trials. Their portfolio includes targeted therapies such as Claudin 18.2 inhibitors and various immuno-oncology agents. The firm operates as a key innovation hub for the broader Reyoung group, integrating modern biotechnology with traditional pharmaceutical expertise.